Drug details

Secuado (asenapine transdermal system)

type of Antipsychotics, Second Generation

Secuado (asenapine) is a transdermal atypical antipsychotic formulation used to treat adults with schizophrenia. Asenapine, the drug contained in Secuado, is also available as a sublingual tablet formulation under the brand name Saphris.

The drug is often used to treat Schizophrenia .

This drug may have the following side effects:

• headache,
• weight gain

The following drugs are related to Secuado, either as a replacement or used together:

• Abilify (aripiprazole)
• Abilify Maintena (aripiprazole extended-release injectable suspension)
• Abilify MyCite (aripiprazole tablets with sensor)
• Aristada (aripiprazole lauroxil extended-release injection)
• Aristada Initio (aripiprazole lauroxil injectable suspension)
• Saphris (asenapine sublingual tablets)
• Clozaril (clozapine)
• Fanapt (iloperidone tablets)
• Prolixin (fluphenazine)
• Geodon (ziprasidone)
• Invega (paliperidone)
• Invega Sustenna (paliperidone palmitate extended-release injectable suspension)
• Invega Trinza (paliperidone palmitate extended-release injectable suspension)
• Latuda (lurasidone hcl tablets for oral administration)
• Mellaril (thioridazine hcl)
• Navane (thiothixene hcl)
• Zyprexa (olanzapine)
• Zyprexa Relprevv (olanzapine extended release injectable suspension)
• Seroquel (quetiapine fumarate)
• Seroquel XR (quetiapine fumarate extended-release tablets)
• Risperdal (risperidone)
• Risperdal Consta (risperidone)